Back to Search
Start Over
Durable response to afatinib rechallenge in a long‐term survivor of non‐small cell lung cancer harboring <scp> EGFR L858R </scp> and <scp>L747V</scp> mutations
- Source :
- Thoracic Cancer. 13:3225-3228
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Pulmonary and Respiratory Medicine
Oncology
General Medicine
Subjects
Details
- ISSN :
- 17597714 and 17597706
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Thoracic Cancer
- Accession number :
- edsair.doi...........477f8c65d0cd9a8210f837d3c6a3cffa